2023Fewer than 5 peopleManufacturer/Trading Company
Shanghai Zhuyao Pharmaceutical Technology Co., Ltd. is a specialized manufacturer and trading company based in Shanghai, China, operating as a professional B2B e-commerce platform for high-end pharmaceutical intermediates. Established in 2023, the company focuses on providing advanced chemical fragments that accelerate drug development by allowing clients to perform direct compound synthesis. Their core product portfolio includes PROTAC Building Blocks (E3 Ligase Ligands and Linkers), ADC Linkers, cytotoxins, and delivery systems such as GalNAc and lipids. Additionally, they specialize in small nucleic acid drug components, including nucleosides, phosphoramidites, and oligonucleotide intermediates. The company maintains professional chemical synthesis and purification workshops equipped with advanced analytical instruments for strict quality inspection. Beyond its standard catalog of heterocyclic compounds, pyridine derivatives, and deuterated compounds, the firm offers technical services such as custom synthesis for research and reference standards. Shanghai Zhuyao Pharmaceutical Technology Co., Ltd. emphasizes green sustainable synthesis and serves the global pharmaceutical industry with technical-grade and research-level chemical solutions.
Product customizationOffers full customization for design and features.
Industry association memberMember of chemBlink Standard Supplier association.
Curious about this supplier? Ask AI for a quick overview.
Key export market
North AmericaNorth America
Similar suppliers you may like
Shanghai Renyoung Pharmaceutical Co., Ltd.
🇨🇳 China
2004101-200 peopleManufacturer/Trading Company
Established brand
OEM manufacturer
Own brand
Product customization
Shipments
112
Key customer
CIPLA
Key market
🇮🇳 India
Description
Shanghai Renyoung Pharmaceutical Co., Ltd. is a professional manufacturer and trading company established in 2004 and headquartered in Shanghai, China. The company specializes in the research, development, and marketing of Active Pharmaceutical Ingredients (APIs), pharmaceutical intermediates, and plant extracts. With a workforce of 101 to 200 employees, including a dedicated R&D team, the company operates as a commercial bridge between domestic chemical factories and global pharmaceutical markets. Their core product portfolio includes Lumefantrine, Tigecycline, Febuxostat, and a wide range of specialized compounds such as steroids, peptides, SARMs, and CBD products. Renyoung Pharmaceutical maintains a strong focus on quality and compliance, holding certifications such as ISO 9001, GMP, CE, UL, and ASME. The company shares holdings in manufacturing facilities that feature cGMP-compliant workshops and synthesis capabilities ranging from laboratory to industrial scales. They offer comprehensive contract manufacturing services, including OEM, ODM, and custom synthesis for highly specialized chemical intermediates. Their global distribution network extends to over 40 countries across North America, Europe, Asia, and Africa, serving a diverse clientele with high-specification agrochemical ingredients, food additives, and dietary supplements.
Screw Air Compressor 10hp$3000
Shanghai Marya Pharmaceutical Engineering and Project Co., Ltd.